PMO Interview with the Innovator Series: Volume 1
Video Categories: PMO Interview with the Innovator Series
Deborah Dunsire, MD, President and CEO of Millennium: The Takeda Oncology Company, and Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation, discuss the issues and vision in improving personalized medicine strategies for patients with multiple myeloma.
Deborah Dunsire, MD, is the former President and CEO of Millennium Pharmaceuticals, Inc.
Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.
Sunil Verma, MD, MSEd, FRCPC takes up the topic of communicating with patients about what they want for their care.